Cell Biotech Statistics

Total Valuation

Cell Biotech has a market cap or net worth of KRW 96.98 billion. The enterprise value is 18.51 billion.

Market Cap	96.98B
Enterprise Value	18.51B

Important Dates

The next estimated earnings date is Friday, February 14, 2025.

Earnings Date	Feb 14, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

Cell Biotech has 6.84 million shares outstanding. The number of shares has decreased by -0.18% in one year.

Current Share Class	n/a
Shares Outstanding	6.84M
Shares Change (YoY)	-0.18%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	34.46%
Owned by Institutions (%)	8.76%
Float	4.49M

Valuation Ratios

The trailing PE ratio is 8.84.

PE Ratio	8.84
Forward PE	n/a
PS Ratio	1.84
PB Ratio	0.83
P/TBV Ratio	0.84
P/FCF Ratio	5.33
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.56, with an EV/FCF ratio of 1.02.

EV / Earnings	1.69
EV / Sales	0.35
EV / EBITDA	1.56
EV / EBIT	2.32
EV / FCF	1.02

Financial Position

The company has a current ratio of 16.33, with a Debt / Equity ratio of 0.01.

Current Ratio	16.33
Quick Ratio	15.46
Debt / Equity	0.01
Debt / EBITDA	0.10
Debt / FCF	0.06
Interest Coverage	120.64

Financial Efficiency

Return on equity (ROE) is 9.72% and return on invested capital (ROIC) is 4.40%.

Return on Equity (ROE)	9.72%
Return on Assets (ROA)	4.20%
Return on Capital (ROIC)	4.40%
Revenue Per Employee	473.87M
Profits Per Employee	98.86M
Employee Count	111
Asset Turnover	0.44
Inventory Turnover	3.81

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +26.41% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+26.41%
50-Day Moving Average	13,824.20
200-Day Moving Average	13,237.15
Relative Strength Index (RSI)	54.24
Average Volume (20 Days)	17,591

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cell Biotech had revenue of KRW 52.60 billion and earned 10.97 billion in profits. Earnings per share was 1,603.39.

Revenue	52.60B
Gross Profit	37.29B
Operating Income	8.05B
Pretax Income	11.40B
Net Income	10.97B
EBITDA	11.98B
EBIT	8.05B
Earnings Per Share (EPS)	1,603.39

Full Income Statement

Balance Sheet

The company has 79.66 billion in cash and 1.18 billion in debt, giving a net cash position of 78.47 billion or 11,466.11 per share.

Cash & Cash Equivalents	79.66B
Total Debt	1.18B
Net Cash	78.47B
Net Cash Per Share	11,466.11
Equity (Book Value)	117.21B
Book Value Per Share	17,126.03
Working Capital	83.83B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 19.11 billion and capital expenditures -906.77 million, giving a free cash flow of 18.20 billion.

Operating Cash Flow	19.11B
Capital Expenditures	-906.77M
Free Cash Flow	18.20B
FCF Per Share	2,659.41

Full Cash Flow Statement

Margins

Gross margin is 70.88%, with operating and profit margins of 15.31% and 20.86%.

Gross Margin	70.88%
Operating Margin	15.31%
Pretax Margin	21.67%
Profit Margin	20.86%
EBITDA Margin	22.77%
EBIT Margin	15.31%
FCF Margin	34.60%

Dividends & Yields

This stock pays an annual dividend of 450.00, which amounts to a dividend yield of 3.18%.

Dividend Per Share	450.00
Dividend Yield	3.18%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	28.06%
Buyback Yield	0.18%
Shareholder Yield	3.36%
Earnings Yield	11.32%
FCF Yield	18.77%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cell Biotech has an Altman Z-Score of 11.33.

Altman Z-Score	11.33
Piotroski F-Score	n/a